Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
9.84
-0.89 (-8.29%)
Oct 23, 2026, 4:00 PM EDT - Market closed
ARCT Market Cap
ARCT has a market cap or net worth of $279.68 million as of October 23, 2026. It is the 18,588th most valuable company in the world and the 3,268th biggest in the United States. Its market cap has decreased by 10.76% in one year.
Market Cap
279.68M
Enterprise Value
111.13M
1-Year Change
-10.76%
Global Rank
Country Rank
#3,268 United States
Category
ChartMarket Cap Chart
Since May 22, 2013, ARCT's market cap has increased from $103.00M to $279.68M, an increase of 171.54%. That is a compound annual growth rate of 7.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 279.70M | 60.56% |
| Dec 31, 2025 | 174.20M | -62.11% |
| Dec 31, 2024 | 459.70M | -45.44% |
| Dec 29, 2023 | 842.60M | 87.54% |
| Dec 30, 2022 | 449.30M | -53.95% |
| Dec 31, 2021 | 975.60M | -8.18% |
| Dec 31, 2020 | 1.06B | 546.29% |
| Dec 31, 2019 | 164.40M | 238.97% |
| Dec 31, 2018 | 48.50M | 54.95% |
| Dec 29, 2017 | 31.30M | -45.94% |
| Dec 30, 2016 | 57.90M | -32.75% |
| Dec 31, 2015 | 86.10M | 69.16% |
| Dec 31, 2014 | 50.90M | -79.27% |
| Dec 31, 2013 | 245.50M | 138.35% |
| May 22, 2013 | 103.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Benitec Biopharma | 301.74M |
| Artiva Biotherapeutics | 300.67M |
| Scribe Therapeutics | 291.64M |
| Inhibikase Therapeutics | 289.50M |
| Opus Genetics | 288.69M |
| Agenus | 284.98M |
| Fulcrum Therapeutics | 280.77M |
| Alector | 271.31M |